Stocks:
5,782
ETFs:
2,400
Exchanges:
11
Market Cap:
$53.48T
24h Vol:
$9.97B
Dominance:
AAPL:5.51%
Stocklytics Platform
Instrument logo  ATRI

Atrion Corp

ATRI
58 / 100
$298.100.47%$1.41

Performance History

Placeholder
Key Stats
Open$293.98
Prev. Close$296.69
EPS12.08
Dividend$8.65
Next Earnings DateAug 8, 2023
Dividend Yield %
2.97%
Market Cap
$524.60M
PE Ratio
24.68
lowhigh
Day Range293.50
301.41
52 Week Range274.98
705.73
Ratios
P/B Ratio
2.17
Revenue
$168.59M
Operating M. %
9.70%
Earnings
$21.30M
Earnings Growth %
-66.80%
EBITDA Margin %
23.30%
ROE %
8.76%
EPS12.08

Score Breakdown

58vs 52. Market Avg.

All Score (58 / 100) is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

ATRIMarket
Value
65
42
Quality
63
46
Ownership
64
39
Growth
32
44
Dividends
37
32

Financial Forecast

AI Price Prediction
line chart placeholder
Analyst Ratings
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$591.85
24H (%)0.04%
24H ($)$0.26
MARKET CAP$561.85B
PRICE$534.97
24H (%)-1.02%
24H ($)-$5.55
MARKET CAP$494.81B
PRICE$152.11
24H (%)0.31%
24H ($)$0.48
MARKET CAP$366.17B
PRICE$101.13
24H (%)0.94%
24H ($)$0.95
MARKET CAP$256.26B

About Atrion Corp (ATRI)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

ISN
-
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. David A. Battat
Headquarters
Allen
Employees
722
add Atrion Corp to watchlist

Keep an eye on Atrion Corp

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.